Vaccines Shouldn't Be Big Business in Poor Countries
1
$ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ o v e r $ 2 6 b i l l i o n d o l l a r s B I G PH A R M A P A Y T O t h e o r d e r o f 6 $ BIG H a v e y o u r cake, a n d e a t i t t o o . Tell GAVI to bring vaccine prices down $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ 1. 5 b illio n d o lla r s Pfizer + GSK have made over $26 billion on the pneumococcal vaccine in rich countries. Pharma gets another $1.5 billion taxpayer- funded subsidy on top of the vaccine price for poor countries. and the icing on top? VACCINES SHOULDN’T BE BIG BUSINESS IN POOR COUNTRIEs
-
Upload
doctors-without-borders-msf -
Category
Documents
-
view
222 -
download
2
description
“Urgent action is needed to address the skyrocketing price to vaccinate a child, which has risen by 2,700 percent over the last decade. Countries where we work will lose their donor support to pay for vaccines soon, and will have to decide which killer diseases they can and can’t afford to protect their children against." - said Dr. Manica Balasegaram, Executive Director of Doctors Without Borders/Médecins Sans Frontières Access Campaign
Transcript of Vaccines Shouldn't Be Big Business in Poor Countries
$$ $
$ $$
$$ $ $
$$
$ $ $ $$ $
$$ $
$ $$
$$ $ $
$$
$ $ $ $$ $
over $26 billion dollars BIG PHARMA
PAY TO the order of6$
BIG
Have y our cake, and eat it too.
Tell GAVI to bring vaccine prices down
$$ $
$ $$
$$ $ $
$$
$ $ $ $$ $
$$ $
$ $$ $
$ $$
$$
$ $ $ $$ $
$$ $
$ $$
$$ $ $
$$
$ $ $ $$ $
$$ $
$ $$
$$ $ $
$$
$ $ $ $$ $
$$ $
$ $$
$$ $ $
$$
$ $ $ $$ $
$1.5 billion dollars
Pfizer + GSK have made over $26 billion on the pneumococcal
vaccine in rich countries.
Pharma gets another $1.5
billion taxpayer-funded subsidy on top of the
vaccine price for poor countries.
and the icing on top?
VACCINES SHOULDN’T BE BIG BUSINESS IN POOR COUNTRIEs
